Recombinant Human HLA-C*08:01&B2M Monomer Protein (HEK293)，Avi & His

HLA-C*08:01 and β2-microglobulin (β2M) are critical components of the major histocompatibility complex (MHC) class I pathway, playing essential roles in mediating immune responses. HLA-C*08:01, a specific allele of the class I MHC molecule, presents peptides to CD8+ T cells, thus influencing immune recognition and response to pathogens and tumors. The study of its recombinant protein, in conjunction with β2M, is of paramount importance for understanding various immunological processes, including allogeneic transplantation, autoimmune diseases, and viral infections. The development of an HLA-C*08:01/β2M monomer allows for an in-depth analysis of ligand binding, T cell receptor interactions, and the structural dynamics of this crucial immune component. Moreover, elucidating the structure-function relationship of this complex aids in identifying peptide epitopes relevant for therapeutic applications and vaccine design. Enhanced understanding of HLA-C*08:01's diverse roles could provide insights into population-based differences in immune responses and susceptibility to diseases, supporting the advancement of personalized medicine strategies. Thus, the comprehensive study of HLA-C*08:01 and β2M not only contributes to basic immunology knowledge but also to the development of novel therapeutic interventions in various immune-related conditions.